Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety, Tolerability and Efficacy Study to Evaluate Subjects With Mild Cognitive Impairment

This study has been completed.
Information provided by (Responsible Party):
Allon Therapeutics Identifier:
First received: January 16, 2007
Last updated: October 18, 2012
Last verified: October 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2008
  Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: July 11, 2012